Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Singapore Institute of Advanced Medicine Holdings Ltd. has entered into a key partnership with Australian biopharmaceutical company EnGeneIC to manufacture and distribute advanced anti-cancer products in Asia and develop cutting-edge cancer theranostics. Under this strategic alliance, EnGeneIC will establish a manufacturing plant in Singapore and lead clinical trials, while the Singaporean company secures exclusive distribution rights in 17 Asian countries. Joint efforts will focus on leveraging EnGeneIC’s proprietary technology to advance cancer treatment and share profits from the sales of these innovative products.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.